Scientometric analysis of mTOR signaling pathway in liver disease
Authors:
Open Access
- 1 February 2020
- journal article
- research article
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 8 (4) , 93
Abstract
Background: The mTOR pathway is vital for homeostasis, metabolism, cancer transplantation and regeneration in the liver. The aim of this study is to use a bibliometric method to reveal current research hotspots and promising future trends in mTOR signaling in liver diseases. Methods: Publications were searched and downloaded from the Web of Science Core Collection (WOSCC) Database. CiteSpace, Carrot2, and VOSviewer programs were utilized to analyze the contribution of various countries/regions, institutes, and authors; and to reveal research hotspots and promising future trends in this research area. Results: Until May 21, 2019, a total of 2,232 papers regarding mTOR signaling pathway in liver disease were included, and each paper was cited 23.21 times on average. The most active country was the USA. 5 landmark articles with centrality and burstiness were determined by co-citation analysis. Research hotspots included “liver transplantation” “hepatic stellate cell proliferation” “NAFLD” “therapy of HCC”. Moreover, six key clusters were discovered during the procedure of “clustering”, including “liver transplantation” “protein synthesis” “mTOR inhibitor” “following early cyclosporine withdrawal” “srebp-1 activation”, and “hepatocellular cancer”. Conclusions: Various scientific methods were applied to reveal scientific productivity, collaboration, and research hotspots in the mTOR signaling pathway in liver disease. Liver transplantation, hepatic stellate cell proliferation, non-alcoholic fatty liver disease (NAFLD), therapy of hepatocellular carcinoma (HCC), cell growth and autophagy, are research hotspots and are likely to be promising in the next few years. Further studies in this field are needed.Keywords
This publication has 48 references indexed in Scilit:
- mTOR Signaling in Growth Control and DiseaseCell, 2012
- Regulation of the SREBP transcription factors by mTORC1Biochemical Society Transactions, 2011
- AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1Nature Cell Biology, 2011
- mTOR: from growth signal integration to cancer, diabetes and ageingNature Reviews Molecular Cell Biology, 2010
- The role of signaling pathways in the development and treatment of hepatocellular carcinomaOncogene, 2010
- Pivotal Role of mTOR Signaling in Hepatocellular CarcinomaGastroenterology, 2008
- Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or LymphangioleiomyomatosisNew England Journal of Medicine, 2008
- Mammalian Target of Rapamycin Pathway Activity in Hepatocellular Carcinomas of Patients Undergoing Liver TransplantationTransplantation, 2007
- Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosisJournal of Hepatology, 2006
- mTOR and P70 S6 Kinase Expression in Primary Liver NeoplasmsClinical Cancer Research, 2004